Home/Filings/4/0000899243-22-006544
4//SEC Filing

Cavalier Jason 4

Accession 0000899243-22-006544

CIK 0001327273other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 9:30 PM ET

Size

9.9 KB

Accession

0000899243-22-006544

Insider Transaction Report

Form 4
Period: 2022-02-12
Cavalier Jason
Chief Financial Officer
Transactions
  • Award

    Stock Option

    2022-02-12+15,60515,605 total
    Exercise: $4.78Exp: 2032-02-11Common Stock (15,605 underlying)
Footnotes (1)
  • [F1]This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following February 12, 2022.

Issuer

Lyra Therapeutics, Inc.

CIK 0001327273

Entity typeother

Related Parties

1
  • filerCIK 0001883290

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 9:30 PM ET
Size
9.9 KB